Li Meizeng, Tian Peijie, Zhao Qing, Ma Xialin, Zhang Yunxiang
School of Basic Medical Science, Weifang Medical University, Weifang, China.
Department of Pathology, Weifang People' s Hospital, Weifang, China.
Front Oncol. 2023 Jan 10;12:1074469. doi: 10.3389/fonc.2022.1074469. eCollection 2022.
In recent years, the role of potassium channels in tumors has been intensively studied. Potassium channel proteins are widely involved in various physiological and pathological processes of cells. The expression and dysfunction of potassium channels are closely related to tumor progression. Potassium channel blockers or activators present antitumor effects by directly inhibiting tumor growth or enhancing the potency of classical antitumor agents in combination therapy. This article reviews the mechanisms by which potassium channels contribute to tumor development in various tumors in recent years, introduces the potential of potassium channels as diagnostic targets and therapeutic means for tumors, and provides further ideas for the proper individualized treatment of tumors.
近年来,钾通道在肿瘤中的作用受到了深入研究。钾通道蛋白广泛参与细胞的各种生理和病理过程。钾通道的表达及功能障碍与肿瘤进展密切相关。钾通道阻滞剂或激活剂通过直接抑制肿瘤生长或在联合治疗中增强经典抗肿瘤药物的效力而呈现出抗肿瘤作用。本文综述了近年来钾通道在各类肿瘤中促进肿瘤发展的机制,介绍了钾通道作为肿瘤诊断靶点和治疗手段的潜力,并为肿瘤的合理个体化治疗提供进一步思路。
Front Oncol. 2023-1-10
Recent Pat CNS Drug Discov. 2007-11
Future Med Chem. 2010-5
Cell Physiol Biochem. 2021-3-6
Acta Neurol Scand. 2022-12
Pharmacol Ther. 2002
Theranostics. 2025-1-1
Int J Mol Sci. 2024-11-19
Cell Death Discov. 2022-8-13
Front Cell Dev Biol. 2022-5-17
Clin Exp Metastasis. 2022-8